Drug Shortage Report for PREMARIN INTRAVENOUS
| Report ID | 186629 |
| Drug Identification Number | 02043386 |
| Brand name | PREMARIN INTRAVENOUS |
| Common or Proper name | PREMARIN INTRAVENOUS |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CONJUGATED ESTROGENS |
| Strength(s) | 25MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1 x 5ML VIAL |
| ATC code | G03CA |
| ATC description | ESTROGENS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-03-15 |
| Actual start date | |
| Estimated end date | 2023-05-31 |
| Actual end date | 2023-06-01 |
| Shortage status | Resolved |
| Updated date | 2023-06-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2023-06-02 | French | Compare |
| v8 | 2023-06-02 | English | Compare |
| v7 | 2023-04-10 | French | Compare |
| v6 | 2023-04-10 | English | Compare |
| v5 | 2023-03-30 | French | Compare |
| v4 | 2023-03-30 | English | Compare |
| v3 | 2023-03-16 | English | Compare |
| v2 | 2023-03-10 | French | Compare |
| v1 | 2023-03-10 | English | Compare |
Showing 1 to 9 of 9